Additionally, while the exact role of vasopressin in ADPKD progression is not clear, it is known that vasopressin V2 receptor antagonists reduces the rate of kidney growth in ADPKD [6]. This evidence concerns the gene AVPR2 and autosomal dominant polycystic kidney disease.